Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 July 2024 | Preview of changes for August 2024
Pharmaceutical |
Change |
---|---|
Adrenaline (Hameln) inj 1 in 1,000, 1 ml ampoule |
new listing (p’code 2685043) |
Amino acid formula (without lysine) |
new listing
|
Amino acid formula (without methionine) |
new listing
|
Amino acid formula (without isoleucine, leucine and valine) |
new listing
|
Amino acid formula (without phenylalanine) |
new listing
|
Amino acid formula (without phenylalanine and tyrosine) |
new listing
|
Amino acid formula (without isoleucine, methionine, threonine and valine) powder 13.1 g protein, 50.1 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can (MMA/PA Anamix Infant) |
new listing (p’code 2386313) |
Amino acid formula (without methionine, threonine and valine) powder (neutral), 5 g protein, 5.4 g carbohydrate, 2.3 g fat and 2.0 g fibre per 18 g sachet (MMA/PA Anamix Junior) |
new listing (p’code 2498812) |
Amoxicillin with clavulanic acid (Curam) grans for oral liq 50 mg with clavulanic acid 12.5 mg per ml, 100 ml |
price increase |
Aprepitant (Emend Tri-Pack) cap 2 × 80 mg and 1 × 125 mg |
price decrease and addition of PSS |
Bimatoprost eye drops 0.03%, 3 ml |
Brand change
|
Bortezomib (DBL Bortezomib) inj 3.5 mg vial |
amended restricted criteria |
Bosentan (Bosentan Dr Reddy’s) tab 62.5 mg and 125 mg |
price decrease and addition of PSS |
Calcium folinate (Eurofolic) inj 10 mg per ml, 100 ml vial |
new listing (p’code 2687364) |
Capsaicin (Zo-Rub Osteo) crm 0.025%, 45 g |
new listing (p’code 2682885) |
Capsaicin (Zo-Rub HP) crm 0.075%, 45 g |
new listing (p’code 2682893) |
Chlorhexidine gluconate (healthE) mouthwash 0.2%, 200 ml |
new listing and addition of PSS (p’code 2393840) |
Clonidine hydrochloride inj 150 mcg per ml, 1 ml ampoule |
Brand change
|
Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine (Infanrix-hexa) inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe |
amended restriction criteria |
Elemental feed with high medium chain triglycerides (Emsogen) powder (neutral), 12.5 g protein, 60 g carbohydrate and 16.4 g fat per 100 g sachet |
new listing (p’code 2508419) |
Eptifibatide (Mylan) inj 2 mg per ml, 10 ml vial |
to be delisted 1 October 2024 |
Essential amino acid formula (Essential Amino Acid Mix) powder (neutral) 79 g protein per 100 g, 200 g can |
new listing (p’code 2389053) |
Glycomacropeptide and amino acid contains some phenylalanine |
new listing
|
Hepatitis B recombinant vaccine (Engerix-B) inj 10 mcg per 0.5 ml prefilled syringe and inj 20 mcg per 1 ml prefilled syringe |
amended restriction criteria |
Hyoscine hydrobromide (Scopoderm TTS) patch 1 mg per 72 hours |
to be delisted 1 January 2025 |
Ipratropium bromide (Pharmascience) nebuliser soln 250 mcg per ml, 2 ml ampoule |
new listing (p’code 2687070) |
Lenalidomide (Revlimid) cap 5 mg, 10 mg, 15 mg and 25 mg, 21 and 28 cap pack |
amended chemical name and to be delisted 1 February 2025 |
Lenalidomide (Viatris) (Lenalidomide Viatris) cap 5 mg, 10 mg, 15 mg and 25 mg |
new listing and addition of PSS
|
Lomustine (Ceenu) cap 10 mg and 40 mg |
to be delisted 1 January 2025 |
Metabolic Products |
amended restriction criteria |
Midazolam inj 1 mg per ml, 5 ml ampoule and inj 5 mg per ml, 3 ml ampoule |
Brand change Midazolam-Baxter – new listing and addition of PSS
Mylan Midazolam and Midazolam Viatris to be delisted 1 January 2025 |
Midodrine (MAR-Midodrine) tab 2.5 mg and 5 mg |
new listing Tab 2.5 mg (p’code 2667851) Tab 5 mg (p’code 2667878) |
Naphazoline hydrochloride eye drops 0.1%, 15 ml |
Brand change
|
Octreotide (Omega) inj 100 mcg per ml, 1 ml vial |
new listing (p’code 2687275) |
Pomalidomide (Pomolide) cap 1 mg, 2 mg, 3 mg and 4 mg |
new listing
|
Protein free supplement containing carbohydrate, fat with added vitamins and minerals (Energivit) powder (neutral) nil added protein and 67 g carbohydrate per 100 g, 400 g can |
new listing (p’code 2000628) |
Risperidone (Risperdal) tab 0.5 mg and 2 mg |
new listing
|
Testosterone (Androderm) patch 5 mg per day |
to be delisted 1 November 2024 |
Thalidomide (Thalomid) cap 50 mg and 100 mg |
amended restriction criteria |